Загрузка страницы

EASL Studio – S3E9 – JHEP Live: ASOs vs siRNAs for treating chronic HBV: Who will be the winner?

In this JHEP Live: Antisense oligonucleotides vs. siRNAs in the treatment of chronic hepatitis B: Who will be the winner, if at all?, the faculty will be discussing the use of antisense oligonucleotides and siRNAs in the treatment of chronic hepatitis B infections. Faculty: Prof. Joerg Petersen (Moderator), Prof. Maria Buti (Faculty), Prof. Man-Fung Yuen (Faculty)

Видео EASL Studio – S3E9 – JHEP Live: ASOs vs siRNAs for treating chronic HBV: Who will be the winner? автора Lifes Mysteries Revealed
Страницу в закладки Мои закладки
Все заметки Новая заметка Страницу в заметки